{"nct_id":"NCT03022045","title":"A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2017-01-26","start_date_type":"ACTUAL","primary_completion_date":"2017-09-17","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}